Cardiovascular Risk in Systemic Autoimmune Diseases: Epigenetic Mechanisms of Immune Regulatory Functions

Autoimmune diseases (AIDs) have been associated with accelerated atherosclerosis (AT) leading to increased cardio- and cerebrovascular disease risk. Traditional risk factors, as well as systemic inflammation mediators, including cytokines, chemokines, proteases, autoantibodies, adhesion receptors, a...

Full description

Saved in:
Bibliographic Details
Main Authors: Chary López-Pedrera, Carlos Pérez-Sánchez, Manuel Ramos-Casals, Monica Santos-Gonzalez, Antonio Rodriguez-Ariza, Ma José Cuadrado
Format: Article
Language:English
Published: Wiley 2012-01-01
Series:Clinical and Developmental Immunology
Online Access:http://dx.doi.org/10.1155/2012/974648
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832567120973529088
author Chary López-Pedrera
Carlos Pérez-Sánchez
Manuel Ramos-Casals
Monica Santos-Gonzalez
Antonio Rodriguez-Ariza
Ma José Cuadrado
author_facet Chary López-Pedrera
Carlos Pérez-Sánchez
Manuel Ramos-Casals
Monica Santos-Gonzalez
Antonio Rodriguez-Ariza
Ma José Cuadrado
author_sort Chary López-Pedrera
collection DOAJ
description Autoimmune diseases (AIDs) have been associated with accelerated atherosclerosis (AT) leading to increased cardio- and cerebrovascular disease risk. Traditional risk factors, as well as systemic inflammation mediators, including cytokines, chemokines, proteases, autoantibodies, adhesion receptors, and others, have been implicated in the development of these vascular pathologies. Yet, the characteristics of vasculopathies may significantly differ depending on the underlying disease. In recent years, many new genes and signalling pathways involved in autoimmunity with often overlapping patterns between different disease entities have been further detected. Epigenetics, the control of gene packaging and expression independent of alterations in the DNA sequence, is providing new directions linking genetics and environmental factors. Epigenetic regulatory mechanisms comprise DNA methylation, histone modifications, and microRNA activity, all of which act upon gene and protein expression levels. Recent findings have contributed to our understanding of how epigenetic modifications could influence AID development, not only showing differences between AID patients and healthy controls, but also showing how one disease differs from another and even how the expression of key proteins involved in the development of each disease is regulated.
format Article
id doaj-art-ad0a0a802fb8440698c424cfaa21fd3f
institution Kabale University
issn 1740-2522
1740-2530
language English
publishDate 2012-01-01
publisher Wiley
record_format Article
series Clinical and Developmental Immunology
spelling doaj-art-ad0a0a802fb8440698c424cfaa21fd3f2025-02-03T01:02:17ZengWileyClinical and Developmental Immunology1740-25221740-25302012-01-01201210.1155/2012/974648974648Cardiovascular Risk in Systemic Autoimmune Diseases: Epigenetic Mechanisms of Immune Regulatory FunctionsChary López-Pedrera0Carlos Pérez-Sánchez1Manuel Ramos-Casals2Monica Santos-Gonzalez3Antonio Rodriguez-Ariza4Ma José Cuadrado5Unidad de Investigación e Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC), Hospital Universitario Reina Sofía, Avda. Menéndez Pidal s/n, 14004 Córdoba, SpainUnidad de Investigación e Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC), Hospital Universitario Reina Sofía, Avda. Menéndez Pidal s/n, 14004 Córdoba, SpainLaboratory of Autoimmune Diseases Josep Font, IDIBAPS, Department of Autoimmune Diseases, Hospital Clínic, C/ Villarroel 170, 08036 Barcelona, SpainLaboratory of Autoimmune Diseases Josep Font, IDIBAPS, Department of Autoimmune Diseases, Hospital Clínic, C/ Villarroel 170, 08036 Barcelona, SpainUnidad de Investigación e Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC), Hospital Universitario Reina Sofía, Avda. Menéndez Pidal s/n, 14004 Córdoba, SpainLupus Research Unit, St Thomas Hospital, Lambeth Palace Road, London SE1 7EH, UKAutoimmune diseases (AIDs) have been associated with accelerated atherosclerosis (AT) leading to increased cardio- and cerebrovascular disease risk. Traditional risk factors, as well as systemic inflammation mediators, including cytokines, chemokines, proteases, autoantibodies, adhesion receptors, and others, have been implicated in the development of these vascular pathologies. Yet, the characteristics of vasculopathies may significantly differ depending on the underlying disease. In recent years, many new genes and signalling pathways involved in autoimmunity with often overlapping patterns between different disease entities have been further detected. Epigenetics, the control of gene packaging and expression independent of alterations in the DNA sequence, is providing new directions linking genetics and environmental factors. Epigenetic regulatory mechanisms comprise DNA methylation, histone modifications, and microRNA activity, all of which act upon gene and protein expression levels. Recent findings have contributed to our understanding of how epigenetic modifications could influence AID development, not only showing differences between AID patients and healthy controls, but also showing how one disease differs from another and even how the expression of key proteins involved in the development of each disease is regulated.http://dx.doi.org/10.1155/2012/974648
spellingShingle Chary López-Pedrera
Carlos Pérez-Sánchez
Manuel Ramos-Casals
Monica Santos-Gonzalez
Antonio Rodriguez-Ariza
Ma José Cuadrado
Cardiovascular Risk in Systemic Autoimmune Diseases: Epigenetic Mechanisms of Immune Regulatory Functions
Clinical and Developmental Immunology
title Cardiovascular Risk in Systemic Autoimmune Diseases: Epigenetic Mechanisms of Immune Regulatory Functions
title_full Cardiovascular Risk in Systemic Autoimmune Diseases: Epigenetic Mechanisms of Immune Regulatory Functions
title_fullStr Cardiovascular Risk in Systemic Autoimmune Diseases: Epigenetic Mechanisms of Immune Regulatory Functions
title_full_unstemmed Cardiovascular Risk in Systemic Autoimmune Diseases: Epigenetic Mechanisms of Immune Regulatory Functions
title_short Cardiovascular Risk in Systemic Autoimmune Diseases: Epigenetic Mechanisms of Immune Regulatory Functions
title_sort cardiovascular risk in systemic autoimmune diseases epigenetic mechanisms of immune regulatory functions
url http://dx.doi.org/10.1155/2012/974648
work_keys_str_mv AT charylopezpedrera cardiovascularriskinsystemicautoimmunediseasesepigeneticmechanismsofimmuneregulatoryfunctions
AT carlosperezsanchez cardiovascularriskinsystemicautoimmunediseasesepigeneticmechanismsofimmuneregulatoryfunctions
AT manuelramoscasals cardiovascularriskinsystemicautoimmunediseasesepigeneticmechanismsofimmuneregulatoryfunctions
AT monicasantosgonzalez cardiovascularriskinsystemicautoimmunediseasesepigeneticmechanismsofimmuneregulatoryfunctions
AT antoniorodriguezariza cardiovascularriskinsystemicautoimmunediseasesepigeneticmechanismsofimmuneregulatoryfunctions
AT majosecuadrado cardiovascularriskinsystemicautoimmunediseasesepigeneticmechanismsofimmuneregulatoryfunctions